B-type natriuretic peptide as a marker for heart failure in patients with acute stroke

Intensive Care Medicine

Volumn 33, Issue 9, 2007, Pages 1587-1593

  Koenig, Matthew A ^a   Puttgen, H Adrian ^a   Prabhakaran, Vivek ^a   Reich, Daniel ^a   Stevens, Robert D ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

B type natriuretic peptide; Heart failure; Intracerebral hemorrhage; Stroke; Subarachnoid hemorrhage

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART FAILURE; ADULT; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUROSCIENCE; RISK; STROKE; STROKE UNIT; SUBARACHNOID HEMORRHAGE; SYSTOLIC DYSFUNCTION; TERTIARY HEALTH CARE; WALL STRESS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE; SUBARACHNOID HEMORRHAGE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548175741     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0704-1     Document Type: Article

References (40)

1. Macmillan CS, Grant IS, Andrews PJ (2002) Pulmonary and cardiac sequelae of subarachnoid haemorrhage: Time for active management? Intensive Care Med 28:1012-1023
2. Kopelnik A, Zaroff JG (2006) Neurocardiogenic injury in neurovascular disorders. Crit Care Clin 22:733-752
3. Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW (2005) Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Hypertension 45:69-74
4. Giannakoulas G, Hatzitolios A, Karvounis H, Koliakos G, Charitandi A, Dimitroulas T, Savopoulas C, Tsirogianni E, Louridas G (2005) N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology 56:723-730
5. Wong KY, McSwiggan S, Kennedy NS, Macwalter RS, Struthers AD (2006) BNP identifies silent myocardial ischaemia in stroke survivors. Heart 92:487-489
6. Mäkikallio AM, Mäkikallio TH, Korpelainen JT, Vuoteenaho O, Tapanainen JM, Ylitalo K, Sotaniemi KA, Huikuri HV, Myllylä V (2005) Natriuretic peptides and mortality after stroke. Stroke 36:1016-1020
7. Nakagawa K, Yamaguchi T, Seida M, Yamada S, Imae S, Tanaka Y, Yamamoto K, Ohno K (2005) Plasma concentration of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 19:157-164
8. Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J, Schulte M, Wild K von, Scherer R (1997) Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid hemorrhage. Lancet 349:245-249
9. Tung PP, Olmsted E, Kopelnik A, Banki NM, Drew BJ, Ko N, Lawton MT, Smith W, Foster E, Young WL, Zaroff JG (2005) Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke 36:1567-1571
10. McKie PM, Burnett JC (2005) B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clin Proc 80:1029-1036
11. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195-203
12. Jason P, Keang TL, Hoe LK (2005) B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 33:2094-2103
13. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ (2004) A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164:1978-1984
14. Dokainish H, Zoghbi WA, Lakkis NM, Quinones MA, Nagueh SF (2004) Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 93:1130-1135
15. Logeart D, Saudubray C, Beyne P, Thabut G, Ennezat PV, Chavelas C, Zanker C, Bouvier E, Solal AC (2002) Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 40:1794-1800
16. Steg PG, Joubin L, McCord J, Abraham WT, Hollander JE, Omland T, Mentré F, McCullough PA, Maisel AS (2005) B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 128:21-29
17. Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB, McCord J, Nowak RM, Aumont MC, Duc P, Hollander JE, Wu AHB, McCollough PA, Maisel AS (2004) Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med 116:363-368
18. Aleman C, Chan SB, Kordick MF (2005) Correlation between chest X-ray and B-type natriuretic peptide in congestive heart failure. Am J Emerg Med 23:501-503
19. Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AHB, Duc P, Omland T, Storrow AB, Krishnaswamy P, Abraham WT, Clopton P, Steg G, Aumont MC, Westheim A, Knudson CW, Perez A, Kamin R, Kazanegra R, Herrmann HC, McCollough PA (2003) Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. J Am Coll Cardiol 41:2010-2017
20. McCollough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omlnad T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AHB, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS (2002) B-type natriuretic peptide and clinical judgment in the emergency diagnosis of heart failure. Circulation 106:416-422
21. Mueller T, Gegenhuber A, Oelz W, Haltmayer M (2005) Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91:606-612
22. Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB (2005) The N-terminal BNP investigation of dyspnea in the Emergency Department (PRIDE) study. Am J Cardiol 95:948-954
23. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996) The progression from hypertension to congestive heart failure. J Am Med Assoc 275:1557-1562
24. Ahmed A, Allman RM, Aronow WS, DeLong JF (2004) Diagnosis of heart failure in older adults: predictive value of dyspnea at rest. Arch Gerontol Geriatr 38:297-307
25. Ahmed A (2002) Clinical characteristics of nursing home residents hospitalized with heart failure. J Am Med Dir Assoc 3:310-313
26. Rodriguez-Garcia JL, Botia E, Sierra A de la, Villanueva MA, González-Spinola J (2005) Significance of elevated blood pressure and its management on the short-term outcome of patients with acute ischemic stroke. Am J Hypertens 18:379-384
27. Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhäupl K, Diener HC, Dominiak P (2003) The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34:1699-1703
28. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators (1998) Low molecular weight heparinoid ORG 10172 (Danaparoid) and outcome after acute ischemic stroke: a randomized controlled trial. J Am Med Assoc 279:1265-1272
29. Lyden P, Lu M, Jackson C, Marler J, Kothari R, Brott T, Zivin J (1999) Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke 30:2347-2354
30. Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, Conroy MB, Localio AR (1999) Reliability and validity of estimating the NIH stroke scale from medical records. Stroke 30:1534-1537
31. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304-1305
32. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577
33. Wijdicks EFM, Schievink WI, Burnett JC (1997) Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage. J Neurosurg 87:275-280
34. Espiner EA, Leikis R, Ferch RD, MacFarlane MR, Bonkowski JA, Frampton CM, Richards AM (2002) The neuro-cardio-endocrine response to acute subarachnoid hemorrhage. Clin Endocrinol 56:629-635
35. Sviri GE, Feinsod M, Soustiel JF (2000) Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage. Stroke 31:118-122
36. Imura H, Nakao K, Itoh (1992) The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol 13:217-249
37. Takahashi K, Totsune K, Sone M, Ohneda M, Murakami O, Itoi K, Mouri T (1992) Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides 13:121-123
38. Gerbes A, Dagnino L, Nguyen T, Nemer M (1994) Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metab 78:1307-1311
39. Myers MG, Norris JW, Hachinski VC, Sole MJ (1981) Plasma norepinephrine in stroke. Stroke 12:200-204
40. Banki NM, Kopelnik A, Dae MW, Miss J, Tung P, Lawton MT, Drew BJ, Foster E, Smith W, Parmley WW, Zaroff JG (2005) Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 112:3314-3319